LACTOCORE
Lactocore Group is a privately funded company led by a team of talented scientists and experienced managers whose mission it is to identify and develop transformative new medicines for mental and metabolic diseases. Lactocore’s expertise spans in silico drug discovery, peptide drug development, and behavioral neuroscience. A lean, efficient, semi-virtual company, Lactocore has a discovery group in Russia, U.S.-centered business development activities, and a network of global Clinical Research Organizations and collaborators, allowing it to conduct cutting-edge R&D at a fraction of the cost of traditional biotech companies.
LACTOCORE
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2018-10-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.lactocore.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Global Site Tag Amazon
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.lactocore.com
- Host name: ec2-54-194-41-141.eu-west-1.compute.amazonaws.com
- IP address: 54.194.41.141
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Lactocore"
Lactocore Group
We develop novel peptide therapeutics using a first in class peptide drug discovery platform. We address unmet medical needs for millions of patients suffering from mental and metabolic disorders. We have invented an R&D …See details»
Lactocore - Crunchbase Company Profile & Funding
Lactocore Group is a privately funded company led by a team of talented scientists and experienced managers whose mission it is to identify and …See details»
Lactocore Group Joins Biolabs Heidelberg, Establishes …
Jul 31, 2023 · The Lactocore Group has joined BioLabs Heidelberg, marking a significant expansion in the European Union of innovative research and development in the field of peptide therapy for the...See details»
Lactocore Group - LinkedIn
Lactocore Group Biotechnology Research Berlin, BE 234 followers Therapeutic peptides with pristine safety against psychiatric and metabolic diseases and computational R&D engine.See details»
Lactocore Group - LinkedIn
Lactocore employs scientifically validated models to assess drug efficacy on various behavioral indicators of anxiety, striving to ensure significant benefits for pets.See details»
Lactocore Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Lactocore. Use the PitchBook Platform to explore the full profile.See details»
Lactocore - Overview, News & Similar companies | ZoomInfo.com
Jul 31, 2023 · View Lactocore (www.lactocore.com) location in Michigan, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Lactocore Company Profile - Office Locations, Competitors, …
Lactocore is a company that develops peptide-based therapies for patients suffering from depression, anxiety, and post-traumatic stress disorder (PTSD). It offers drug candidates that …See details»
Clinical Trials Arena
Nov 6, 2023 · Lactocore Group has started an investigational new drug (IND) application-enabling studies and plans to advance its lead peptide therapy LCGA-17 to clinical development in the …See details»
Dr. Anton Malyshev, CEO of Lactocore, Explores How …
Mar 21, 2022 · Dr. Anton Malyshev, CEO of Lactocore. Lactocore Group is a privately funded company with a team of biologists, biochemists and computational biologists (10 PhDs) exploring transformative new medicines …See details»
Lactocore - Products, Competitors, Financials, Employees, …
Lactocore develops novel peptide therapeutics. It uses a structure-based drug discovery platform offering treatments for mental health and metabolic disorders such as type 2 diabetes and …See details»
Lactocore - Michigan Life Sciences & Innovation Center
The company is using an approach of rational drug design against carefully selected CNS (central nervous system) targets, ensuring highly specific and efficient peptide drug candidates. For …See details»
Lactocore - Contacts, Employees, Board Members, Advisors
Lactocore is a biotech company that develops novel peptide therapeutics using cutting-edge technologiesSee details»
Lactocore's Board of Directors Team - Team members and org …
Lactocore's Board of Directors includes Randall D. Marshall and 10 others.See details»
Lactocore Group : Quotes, Address, Contact - News-Medical.net
Nov 16, 2024 · Lactocore Group develops novel peptide therapeutics using a first in class structure-based drug discovery platform. They addresses unmet medical needs for millions of …See details»
Lactocore Group findings show promise in treating anxiety and ...
NEWTON, Mass., Feb. 3, 2022 /PRNewswire/ -- Biotechnology company Lactocore Group has identified novel milk-derived peptides that hold potential for developing safer and more effective...See details»
Lactocore Group findings show promise in treating anxiety and …
NEWTON, Mass., Feb. 3, 2022 /PRNewswire/ -- Biotechnology company Lactocore Group has identified novel milk-derived peptides that hold potential for developing safer and more effective...See details»
Innovative Peptide Discovery by Lactocore Scientists Promises ...
May 6, 2024 · Lactocore, a US-German biotech startup founded by neuroscientists, has discovered a new, potentially safer, and more efficient way to treat depression, ADHD, and …See details»
Milk ingredients have potential for psychiatric treatments
Feb 7, 2022 · Massachusetts-based biotechnology company Lactocore Group said it has identified novel milk-derived peptides that hold potential for developing safer and more …See details»
Lactocore Group leverages milk peptides to combat inflammaging
Feb 21, 2024 · Addressing this conundrum, Lactocore Group, founded by Dr. Anton Malyshev, focuses on isolating and optimizing milk’s most beneficial components, specifically the …See details»